Joshua T Brumm insider trades
Open-market stock purchases and sales by Joshua T Brumm, Chief Executive Officer at Crescent Biopharma, Inc, from SEC Form 4 filings since Feb 17, 2012.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Sep 18, 2026 | CBIO Crescent Biopharma, Inc | Sold | $131K |
| Sep 16, 2026 | CBIO Crescent Biopharma, Inc | Sold | $28.8K |
| Jun 22, 2026 | CBIO Crescent Biopharma, Inc | Sold | $761K |
| Dec 15, 2025 | CBIO Crescent Biopharma, Inc | Bought (not open market) | — |
| Dec 15, 2025 | CBIO Crescent Biopharma, Inc | Bought (not open market) | — |
| Dec 15, 2025 | CBIO Crescent Biopharma, Inc | Bought (not open market) | — |
| Dec 8, 2025 | CBIO Crescent Biopharma, Inc | Bought (not open market) | — |
Companies traded
- CBIO Crescent Biopharma, Inc: 3 sales, last Sep 18, 2026
- DYN Dyne Therapeutics, Inc: 31 sales, last Mar 11, 2024
- KLDO Kaleido Biosciences, Inc: other filings, last Mar 4, 2019
- VSAR Versartis, Inc: 1 buy, 12 sales, last Oct 19, 2017
- PCYC Pharmacyclics Inc: other filings, last Oct 26, 2012
- ZLTQ Zeltiq Aesthetics Inc: other filings, last Feb 17, 2012